{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:46:16Z","timestamp":1789159576589,"version":"build-2803163510"},"reference-count":151,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Post-traumatic stress disorder (PTSD) is a devastating psychiatric disorder afflicting millions of people around the world. Characterized by severe anxiety, intrusive thoughts, pervasive nightmares, an assortment of somatic symptoms, associations with severe long-term health problems, and an elevated risk of suicide, as much as 40\u201370% of patients suffer from refractory disease. 3,4-Methylenedioxy-methamphetamine (MDMA), like classic psychedelics such as psilocybin, have been used to enhance the efficacy of psychotherapy almost since their discovery, but due to their perceived potential for abuse and inclusion on USFDA (United States Food and Drug Administration) schedule 1, research into the mechanism by which they produce improvements in PTSD symptomology has been limited. Nevertheless, several compelling rationales have been explored, with the pro-social effects of MDMA thought to enhance therapeutic alliance and thus facilitate therapist-assisted trauma processing. This may be insufficient to fully explain the efficacy of MDMA in the treatment of psychiatric illness. Molecular mechanisms such as the MDMA mediated increase of brain-derived neurotrophic factor (BDNF) availability in the fear memory learning pathways combined with MDMA's pro-social effects may provide a more nuanced explanation for the therapeutic actions of MDMA.<\/jats:p>","DOI":"10.3389\/fpsyt.2022.991753","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T05:22:25Z","timestamp":1665552145000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy"],"prefix":"10.3389","volume":"13","author":[{"given":"Robert J.","family":"Sottile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Vida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","article-title":"Reviewing the potential of psychedelics for the treatment of PTSD","volume":"23","author":"Krediet","year":"2020","journal-title":"Int J Neuropsychopharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neulet.2016.07.004","article-title":"MDMA and PTSD treatment: PTSD: from novel pathophysiology to innovative therapeutics","volume":"649","author":"Sessa","year":"2017","journal-title":"Neurosci Lett."},{"key":"B3","doi-asserted-by":"publisher","first-page":"901","DOI":"10.2147\/RMHP.S300656","article-title":"The use of classic hallucinogens\/psychedelics in a therapeutic context: healthcare policy opportunities and challenges","volume":"14","author":"Dos Santos","year":"2021","journal-title":"Risk Manag Healthc Policy."},{"key":"B4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","article-title":"The promises and perils of psychedelic pharmacology for psychiatry","volume":"21","author":"McClure-Begley","year":"2022","journal-title":"Nat Rev Drug Discov."},{"key":"B5","doi-asserted-by":"publisher","first-page":"863088","DOI":"10.3389\/fpsyt.2022.863088","article-title":"Entactogens: how the name for a novel class of psychoactive agents originated","volume":"13","author":"Nichols","year":"2022","journal-title":"Front Psychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fpsyt.2019.00650","article-title":"Breakthrough for trauma treatment: safety and efficacy of MDMA-assisted psychotherapy compared to paroxetine and sertraline","volume":"10","author":"Feduccia","year":"2019","journal-title":"Front Psychiatry."},{"key":"B7","unstructured":"KennyBJ\n            ZitoPM\n          Controlled Substance Schedules. In StatPearls.2021"},{"key":"B8","unstructured":"Breakthrough Therapy"},{"key":"B9","first-page":"112","article-title":"Substance misuse and substance use disorders: why do they matter in healthcare?","volume":"128","author":"McLellan","year":"2017","journal-title":"Trans Am Clin Climatol Assoc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/SAR.S37258","article-title":"3,4-methylenedioxymethamphetamine (MDMA): current perspectives","volume":"4","author":"Meyer","year":"2013","journal-title":"Subst Abuse Rehabil."},{"key":"B11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neuropharm.2018.01.020","article-title":"\u201cEcstasy\u201d to addiction: Mechanisms and reinforcing effects of three synthetic cathinone analogs of MDMA","volume":"133","author":"Dolan","year":"2018","journal-title":"Neuropharmacology."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00213-014-3752-6","article-title":"MDMA: a social drug in a social context","volume":"232","author":"Kirkpatrick","year":"2015","journal-title":"Psychopharmacology."},{"key":"B13","unstructured":"The pharmacology and toxicology of \u201cecstasy\u201d (MDMA) and related drugs91728\n            KalantH\n          11599334CMAJ.1652001"},{"key":"B14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fpsyt.2019.00138","article-title":"A review of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy","volume":"10","author":"Sessa","year":"2019","journal-title":"Front Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12402-012-0085-3","article-title":"Stigma in attention deficit hyperactivity disorder","volume":"4","author":"Mueller","year":"2012","journal-title":"Atten Defic Hyperact Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"CD007990","DOI":"10.1002\/14651858.CD007990.pub3","article-title":"Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders","volume":"6","author":"Osland","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12991-020-00283-6","article-title":"MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn't","volume":"19","author":"Morgan","year":"2020","journal-title":"Ann Gen Psychiatry."},{"key":"B18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.pnpbp.2018.03.003","article-title":"MDMA-assisted psychotherapy for PTSD: are memory reconsolidation and fear extinction underlying mechanisms?","volume":"84","author":"Feduccia","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e2824","DOI":"10.1002\/hup.2824","article-title":"Potential processes of change in MDMA-Assisted therapy for social anxiety disorder: enhanced memory reconsolidation, self-transcendence, therapeutic relationships","volume":"37","author":"Luoma","year":"2022","journal-title":"Hum Psychopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.31887\/DCNS.2011.13.2\/jsherin","article-title":"Post-traumatic stress disorder: the neurobiological impact of psychological trauma","volume":"13","author":"Sherin","year":"2011","journal-title":"Dialogues Clin Neurosci."},{"key":"B21","first-page":"77","article-title":"WHO's ICF and functional status information in health records","volume":"24","author":"Ust\u00fcn","year":"2003","journal-title":"Health Care Financ Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1177\/0883073814533595","article-title":"International Classification of Functioning, Disability and Health (ICF) as a framework for change: revolutionizing rehabilitation","volume":"29","author":"Vargus-Adams","year":"2014","journal-title":"J Child Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpsychires.2021.01.039","article-title":"Functional impairment in posttraumatic stress disorder: a systematic review and meta-analysis","volume":"136","author":"Jellestad","year":"2021","journal-title":"J Psychiatr Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.31887\/DCNS.2018.20.3\/ccarvajal","article-title":"Posttraumatic stress disorder as a diagnostic entity - clinical perspectives","volume":"20","author":"Carvajal","year":"2018","journal-title":"Dialogues Clin Neurosci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1386988","DOI":"10.1080\/20008198.2017.1386988","article-title":"Comparison of DSM-5 and proposed ICD-11 criteria for PTSD with DSM-IV and ICD-10: changes in PTSD prevalence in military personnel","volume":"8","author":"Kuester","year":"2017","journal-title":"Eur J Psychotraumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/bs7010007","article-title":"Posttraumatic stress disorder in the DSM-5: controversy, change, conceptual considerations","volume":"7","author":"Pai","year":"2017","journal-title":"Behav Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/070674371405900902","article-title":"Posttraumatic stress disorder in adults: impact, comorbidity, risk factors, and treatment","volume":"59","author":"Sareen","year":"2014","journal-title":"Can J Psychiatry."},{"key":"B28","first-page":"546","article-title":"A review of PTSD and current treatment strategies","volume":"118","author":"Schrader","year":"2021","journal-title":"Mo Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/wps.20656","article-title":"Post-traumatic stress disorder: a state-of-the-art review of evidence and challenges","volume":"18","author":"Bryant","year":"2019","journal-title":"World Psychiatry."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1920476","DOI":"10.1001\/jamanetworkopen.2019.20476","article-title":"Association between posttraumatic stress disorder and mortality among responders and civilians following the september 11, 2001, disaster","volume":"3","author":"Giesinger","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jagp.2015.04.001","article-title":"Is post-traumatic stress disorder associated with premature senescence? A review of the literature","volume":"23","author":"Lohr","year":"2015","journal-title":"Am J Geriatr Psychiatry."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/j.2051-5545.2010.tb00254.x","article-title":"The long-term costs of traumatic stress: intertwined physical and psychological consequences","volume":"9","author":"McFarlane","year":"2010","journal-title":"World Psychiatry."},{"key":"B33","doi-asserted-by":"publisher","first-page":"113506","DOI":"10.1016\/j.psychres.2020.113506","article-title":"The long-term consequences of trauma and posttraumatic stress disorder symptoms on later life cognitive function and dementia risk","volume":"294","author":"Nilaweera","year":"2020","journal-title":"Psychiatry Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"h6161","DOI":"10.1136\/bmj.h6161","article-title":"Post-traumatic stress disorder","volume":"351","author":"Bisson","year":"2015","journal-title":"BMJ."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3389\/fpsyg.2020.01998","article-title":"Posttraumatic stress disorder, suicidal ideation, and suicidal self-directed violence among U.S. military personnel and veterans: a systematic review of the literature from 2010 to 2018","volume":"11","author":"Holliday","year":"2020","journal-title":"Front Psychol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jad.2020.10.009","article-title":"Suicide risk in people with post-traumatic stress disorder: a cohort study of 3.1 million people in Sweden","volume":"279","author":"Fox","year":"2021","journal-title":"J Affect Disord."},{"key":"B37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3389\/fphar.2019.00404","article-title":"Therapeutic challenges of post-traumatic stress disorder: focus on the dopaminergic system","volume":"10","author":"Torrisi","year":"2019","journal-title":"Front Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e12520","DOI":"10.1111\/gbb.12520","article-title":"Combined brain-derived neurotrophic factor with extinction training alleviate impaired fear extinction in an animal model of post-traumatic stress disorder","volume":"18","author":"Kataoka","year":"2019","journal-title":"Genes Brain Behav."},{"key":"B39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1503\/jpn.170021","article-title":"Mindfulness-based treatments for posttraumatic stress disorder: a review of the treatment literature and neurobiological evidence","volume":"43","author":"Boyd","year":"2018","journal-title":"J Psychiatry Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fnbeh.2018.00258","article-title":"Treating PTSD: a review of evidence-based psychotherapy interventions","volume":"12","author":"Watkins","year":"2018","journal-title":"Front Behav Neurosci."},{"key":"B41","unstructured":"Department of Veterans AffairsVA\/DOD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder2017"},{"key":"B42","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/jts.21840","article-title":"Finalizing PTSD in DSM-5: getting here from there and where to go next","volume":"26","author":"Friedman","year":"2013","journal-title":"J Trauma Stress"},{"key":"B43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.9740\/mhc.2019.11.373","article-title":"Treatment of posttraumatic stress disorder: focus on pharmacotherapy","volume":"9","author":"Ehret","year":"2019","journal-title":"Ment Health Clin."},{"key":"B44","doi-asserted-by":"publisher","first-page":"18ac12473","DOI":"10.4088\/JCP.18ac12473","article-title":"Are there effective psychopharmacologic treatments for PTSD?","volume":"80","author":"Akiki","year":"2018","journal-title":"J Clin Psychiatry."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1802920","DOI":"10.1080\/20008198.2020.1802920","article-title":"Pharmacological therapy for post-traumatic stress disorder: a systematic review and meta-analysis of monotherapy, augmentation and head-to-head approaches","volume":"12","author":"Hoskins","year":"2021","journal-title":"Eur J Psychotraumatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3389\/fphar.2020.00559","article-title":"Comparative efficacy and acceptability of pharmaceutical management for adults with post-traumatic stress disorder: a systematic review and meta-analysis","volume":"11","author":"Huang","year":"2020","journal-title":"Front Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e25414","DOI":"10.7759\/cureus.25414","article-title":"Unraveling the mysteries of mental illness with psilocybin","volume":"14","author":"Sotille","year":"2022","journal-title":"Cureus."},{"key":"B48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/02791072.2020.1817639","article-title":"Efficacy of psychoactive drugs for the treatment of posttraumatic stress disorder: a systematic review of MDMA, Ketamine, LSD and Psilocybin","volume":"53","author":"Varker","year":"2021","journal-title":"J Psychoactive Drugs."},{"key":"B49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cpr.2017.10.009","article-title":"Long-term efficacy of psychotherapy for posttraumatic stress disorder: a meta-analysis of randomized controlled trials","volume":"59","author":"Kline","year":"2018","journal-title":"Clin Psychol Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1729633","DOI":"10.1080\/20008198.2020.1729633","article-title":"Psychological therapies for post-traumatic stress disorder in adults: systematic review and meta-analysis","volume":"11","author":"Lewis","year":"2020","journal-title":"Eur J Psychotraumatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1947570","DOI":"10.1080\/20008198.2021.1947570","article-title":"A meta-analysis of dropout from evidence-based psychological treatment for post-traumatic stress disorder (PTSD) in children and young people","volume":"12","author":"Simmons","year":"2021","journal-title":"Eur J Psychotraumatol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1037\/ser0000329","article-title":"Therapeutic alliance across trauma-focused and non-trauma-focused psychotherapies among veterans with PTSD","volume":"17","author":"Chen","year":"2020","journal-title":"Psychol Serv."},{"key":"B53","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3389\/fpsyt.2019.00943","article-title":"Therapeutic use of LSD in psychiatry: a systematic review of randomized-controlled clinical trials","volume":"10","author":"Fuentes","year":"2020","journal-title":"Front Psychiatry."},{"key":"B54","doi-asserted-by":"publisher","first-page":"120302","DOI":"10.1016\/j.jns.2022.120302","article-title":"Review of potential psychedelic treatments for PTSD","volume":"439","author":"Henner","year":"2022","journal-title":"J Neurol Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3389\/fphar.2018.00733","article-title":"Psychedelic-assisted psychotherapy: a paradigm shift in psychiatric research and development","volume":"9","author":"Schenberg","year":"2018","journal-title":"Front Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1853379","DOI":"10.1080\/20008198.2020.1853379","article-title":"Pharmacological-assisted psychotherapy for post-traumatic stress disorder: a systematic review and meta-analysis","volume":"12","author":"Hoskins","year":"2021","journal-title":"Eur J Psychotraumatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0269881117711712","article-title":"Therapeutic effect of increased openness: investigating mechanism of action in MDMA-assisted psychotherapy","volume":"31","author":"Wagner","year":"2017","journal-title":"J Psychopharmacol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.31887\/DCNS.2019.21.2\/dnutt","article-title":"Psychedelic drugs-a new era in psychiatry?","volume":"21","author":"Nutt","year":"2019","journal-title":"Dialogues Clin Neurosci."},{"key":"B59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/01.NAJ.0000753464.35523.29","article-title":"Psychedelic-assisted therapy: emerging treatments in mental health disorders","volume":"121","author":"Penn","year":"2021","journal-title":"Am J Nurs."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1503\/cmaj.141124","article-title":"Psychedelic medicine: a re-emerging therapeutic paradigm","volume":"187","author":"Tupper","year":"2015","journal-title":"CMAJ."},{"key":"B62","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/jts.22696","article-title":"Sleep quality improvements after MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder","volume":"34","author":"Ponte","year":"2021","journal-title":"J Trauma Stress."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1021\/acschemneuro.8b00155","article-title":"Dark classics in chemical neuroscience: 3,4-Methylenedioxymethamphetamine","volume":"9","author":"Dunlap","year":"2018","journal-title":"ACS Chem Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3390\/ph4070992","article-title":"Methylenedioxymethamphetamine (MDMA, \u2018Ecstasy'): neurodegeneration versus neuromodulation","volume":"4","author":"Puerta","year":"2011","journal-title":"Pharmaceuticals."},{"key":"B65","unstructured":"PubChem Compound Summary for CID 1615, 3,4-Methylenedioxymethamphetamine"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1111\/j.1360-0443.2010.02948.x","article-title":"Rediscovering MDMA (ecstasy): the role of the American chemist Alexander T. Shulgin","volume":"105","author":"Benzenhofer","year":"2010","journal-title":"Addiction."},{"key":"B67","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/00007691-200404000-00009","article-title":"Human pharmacology of MDMA","volume":"26","author":"de la Torre","year":"2004","journal-title":"Ther Drug Monit."},{"key":"B68","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/BF00178519","article-title":"3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors","volume":"88","author":"Lyon","year":"1986","journal-title":"Psychopharmacology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"381","DOI":"10.32598\/bcn.9.10.485","article-title":"MDMA and the brain: a short review on the role of neurotransmitters in neurotoxicity","volume":"11","author":"Mustafa","year":"2020","journal-title":"Basic Clin Neurosci."},{"key":"B70","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neubiorev.2015.08.016","article-title":"The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): controlled studies in humans and laboratory animals","volume":"57","author":"Kamilar-Britt","year":"2015","journal-title":"Neurosci Biobehav Rev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00213-009-1635-z","article-title":"Effects of MDMA on sociability and neural response to social threat and social reward","volume":"207","author":"Bedi","year":"2009","journal-title":"Psychopharmacology."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1093\/scan\/nsu035","article-title":"'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content","volume":"9","author":"Wardle","year":"2014","journal-title":"Soc Cogn Affect Neurosci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1007\/s00213-016-4396-5","article-title":"The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies","volume":"233","author":"Vegting","year":"2016","journal-title":"Psychopharmacology."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1081\/JA-200066810","article-title":"An in-depth qualitative examination of the ecstasy experience: results of a focus group with ecstasy-using college students","volume":"40","author":"Levy","year":"2005","journal-title":"Subst Use Misuse."},{"key":"B75","doi-asserted-by":"publisher","first-page":"113894","DOI":"10.1016\/j.expneurol.2021.113894","article-title":"Neurotoxicity of MDMA: main effects and mechanisms","volume":"347","author":"Costa","year":"2022","journal-title":"Exp Psychol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1515\/bc.2011.016","article-title":"The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine","volume":"392","author":"Steinkellner","year":"2011","journal-title":"Biol Chem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nat Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00213-022-06086-9","article-title":"MDMA and memory, addiction, and depression: dose-effect analysis","volume":"239","author":"Pantoni","year":"2022","journal-title":"Psychopharmacology."},{"key":"B79","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00213-005-0174-5","article-title":"MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment","volume":"189","author":"Verrico","year":"2007","journal-title":"Psychopharmacology."},{"key":"B80","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1002\/jcph.1918","article-title":"Pharmacology of drugs used as stimulants","volume":"61","author":"Docherty","year":"2021","journal-title":"J Clin Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"eaaw6435","DOI":"10.1126\/scitranslmed.aaw6435","article-title":"Distinct neural mechanisms for the prosocial and rewarding properties of MDMA","volume":"11","author":"Heifets","year":"2019","journal-title":"Sci Transl Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1124\/mol.115.101394","article-title":"Binding mode selection determines the action of ecstasy homologs at monoamine transporters","volume":"89","author":"Sandtner","year":"2016","journal-title":"Mol Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1177\/0269881120920420","article-title":"Beyond ecstasy: alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy","volume":"35","author":"Oeri","year":"2021","journal-title":"J Psychopharmacol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroimage.2019.04.007","article-title":"Receptor-Enriched Analysis of functional connectivity by targets (REACT): a novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA","volume":"195","author":"Dipasquale","year":"2019","journal-title":"Neuroimage."},{"key":"B85","doi-asserted-by":"publisher","first-page":"e43107","DOI":"10.1371\/journal.pone.0043107","article-title":"Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice","volume":"7","author":"Vidal-Infer","year":"2012","journal-title":"PLoS ONE."},{"key":"B86","doi-asserted-by":"publisher","first-page":"S311","DOI":"10.4103\/0972-6748.328839","article-title":"Memory: Neurobiological mechanisms and assessment","volume":"30","author":"Mujawar","year":"2021","journal-title":"Ind. Psychiatry J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3389\/fpsyg.2017.01454","article-title":"The influences of emotion on learning and memory","volume":"8","author":"Tyng","year":"2017","journal-title":"Front Psychol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.17179\/excli2020-2612","article-title":"State-dependent memory and its modulation by different brain areas and neurotransmitters","volume":"19","author":"Zarrindast","year":"2020","journal-title":"EXCLI J."},{"key":"B89","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.tics.2018.07.015","article-title":"Memory control: a fundamental mechanism of emotion regulation","volume":"22","author":"Engen","year":"2018","journal-title":"Trends Cogn Sci."},{"key":"B90","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00213-018-5104-4","article-title":"Mechanisms of fear learning and extinction: synaptic plasticity-fear memory connection","volume":"236","author":"Luchkina","year":"2019","journal-title":"Psychopharmacology."},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.21201.1","article-title":"Fear conditioning and the basolateral amygdala","volume":"9","author":"Sun","year":"2020","journal-title":"F1000Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nlm.2017.03.001","article-title":"Extinction after fear memory reactivation fails to eliminate renewal in rats","volume":"142","author":"Goode","year":"2017","journal-title":"Neurobiol Learn Mem."},{"key":"B93","doi-asserted-by":"publisher","first-page":"113331","DOI":"10.1016\/j.expneurol.2020.113331","article-title":"PTSD-related neuroimaging abnormalities in brain function, structure, and biochemistry","volume":"330","author":"Harnett","year":"2020","journal-title":"Exp Neurol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-3-319-94593-4_2","article-title":"Neural circuits mediating fear learning and extinction","volume":"21","author":"Marek","year":"2018","journal-title":"Syst Neurosci."},{"key":"B95","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/brainsci10080502","article-title":"Amygdala: neuroanatomical and morphophysiological features in terms of neurological and neurodegenerative diseases","volume":"10","author":"Nikolenko","year":"2020","journal-title":"Brain Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.aan8868","article-title":"What constitutes the prefrontal cortex?","volume":"358","author":"Carlen","year":"2017","journal-title":"Science."},{"key":"B97","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3390\/bs3020298","article-title":"Hippocampal physiology, structure and function and the neuroscience of schizophrenia: a unified account of declarative memory deficits, working memory deficits and schizophrenic symptoms","volume":"3","author":"Wible","year":"2013","journal-title":"Behav Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fnmol.2017.00396","article-title":"Fear conditioning downregulates Rac1 activity in the basolateral amygdala astrocytes to facilitate the formation of fear memory","volume":"10","author":"Liao","year":"2017","journal-title":"Front Mol Neurosci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.brainres.2014.10.010","article-title":"Out with the old and in with the new: synaptic mechanisms of extinction in the amygdala","volume":"1621","author":"Maren","year":"2015","journal-title":"Brain Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00441-020-03260-3","article-title":"Neurotrophin signalling in amygdala-dependent cued fear learning","volume":"382","author":"Meis","year":"2020","journal-title":"Cell Tissue Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1093\/cercor\/bhx282","article-title":"Contextual fear extinction induces hippocampal metaplasticity mediated by metabotropic glutamate receptor 5","volume":"28","author":"Stansley","year":"2018","journal-title":"Cereb Cortex."},{"key":"B102","doi-asserted-by":"publisher","first-page":"107117","DOI":"10.1016\/j.nlm.2019.107117","article-title":"Learning-induced intrinsic and synaptic plasticity in the rodent medial prefrontal cortex","volume":"169","author":"Porter","year":"2020","journal-title":"Neurobiol Learn Mem."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/mp.2016.78","article-title":"Retrieving fear memories, as time goes by\u2026","volume":"21","author":"Do Monte","year":"2016","journal-title":"Mol Psychiatry."},{"key":"B104","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00213-018-5121-3","article-title":"Neurochemical and molecular mechanisms underlying the retrieval-extinction effect","volume":"236","author":"Cahill","year":"2019","journal-title":"Psychopharmacology."},{"key":"B105","doi-asserted-by":"publisher","first-page":"635879","DOI":"10.3389\/fnsyn.2021.635879","article-title":"Dopamine in fear extinction","volume":"13","author":"Salinas-Hern\u00e1ndez","year":"2021","journal-title":"Front Synaptic Neurosci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"46071","DOI":"10.1038\/srep46071","article-title":"Preventing the return of fear using reconsolidation updating and methylene blue is differentially dependent on extinction learning","volume":"7","author":"Auchter","year":"2017","journal-title":"Sci Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1007\/s00213-017-4684-8","article-title":"Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)","volume":"234","author":"Young","year":"2017","journal-title":"Psychopharmacology."},{"key":"B108","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2183\/pjab.96.008","article-title":"Function and mechanisms of memory destabilization and reconsolidation after retrieval","volume":"96","author":"Kida","year":"2020","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00213-018-5086-2","article-title":"Reconsolidation\/destabilization, extinction and forgetting of fear memory as therapeutic targets for PTSD","volume":"236","author":"Kida","year":"2019","journal-title":"Psychopharmacology."},{"key":"B110","doi-asserted-by":"publisher","first-page":"e25224","DOI":"10.7554\/eLife.25224.018","article-title":"Amount of fear extinction changes its underlying mechanisms","volume":"6","author":"An","year":"2017","journal-title":"Elife."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1523\/JNEUROSCI.3137-14.2015","article-title":"Revisiting the role of infralimbic cortex in fear extinction with optogenetics","volume":"35","author":"Do-Monte","year":"2015","journal-title":"J Neurosci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.3390\/jcm9092951","article-title":"Neurophysiology and psychopathology underlying PTSD and recent insights into the PTSD therapies\u2014A comprehensive review","volume":"9","author":"Aliev","year":"2020","journal-title":"J Clin Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11920-017-0829-z","article-title":"Synaptic loss and the pathophysiology of PTSD: implications for ketamine as a prototype novel therapeutic","volume":"19","author":"Krystal","year":"2017","journal-title":"Curr Psychiatry Rep."},{"key":"B114","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.1523\/JNEUROSCI.4287-13.2014","article-title":"Impaired contextual modulation of memories in PTSD: an fMRI and psychophysiological study of extinction retention and fear renewal","volume":"34","author":"Garfinkel","year":"2014","journal-title":"J Neurosci."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.biopsych.2009.06.026","article-title":"Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder","volume":"66","author":"Milad","year":"2009","journal-title":"Biol Psychiatry."},{"key":"B116","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/npp.2015.180","article-title":"Stress and fear extinction","volume":"41","author":"Maren","year":"2016","journal-title":"Neuropsychopharmacology."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1568132","DOI":"10.1080\/20008198.2019.1568132","article-title":"Fear extinction learning improvement in PTSD after EMDR therapy: an fMRI study","volume":"10","author":"Rousseau","year":"2019","journal-title":"Eur J Psychotraumatol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neubiorev.2016.07.014","article-title":"The centrality of fear extinction in linking risk factors to PTSD: a narrative review","volume":"69","author":"Zuj","year":"2016","journal-title":"Neurosci Biobehav Rev."},{"key":"B119","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3389\/fpsyg.2019.02394","article-title":"Traumatic stress produces delayed alterations of synaptic plasticity in basolateral amygdala","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Psychol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.biopsych.2016.11.015","article-title":"Amygdala reactivity and anterior cingulate habituation predict posttraumatic stress disorder symptom maintenance after acute civilian trauma","volume":"81","author":"Stevens","year":"2017","journal-title":"Biol Psychiatry."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/archgenpsychiatry.2012.50","article-title":"Amygdala volume changes in posttraumatic stress disorder in a large case-controlled veterans group","volume":"69","author":"Morey","year":"2012","journal-title":"Arch Gen Psychiatry."},{"key":"B122","doi-asserted-by":"publisher","first-page":"100217","DOI":"10.1016\/j.ynstr.2020.100217","article-title":"Amygdala functional connectivity in the acute aftermath of trauma prospectively predicts severity of posttraumatic stress symptoms","volume":"12","author":"Belleau","year":"2020","journal-title":"Neurobiol Stress."},{"key":"B123","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1177\/1073858409333072","article-title":"Posttraumatic stress disorder: the role of medial prefrontal cortex and amygdala","volume":"15","author":"Koenigs","year":"2009","journal-title":"Neuroscientist."},{"key":"B124","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/0963721420917691","article-title":"Reduced memory coherence for negative events and its relationship to posttraumatic stress disorder","volume":"29","author":"Bisby","year":"2020","journal-title":"Curr Dir Psychol Sci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41398-020-00974-4","article-title":"The association of PTSD symptom severity with amygdala nuclei volumes in traumatized youths","volume":"10","author":"Ousdal","year":"2020","journal-title":"Transl Psychiatry."},{"key":"B126","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev-pharmtox-010818-021701","article-title":"The neurobiology and pharmacotherapy of posttraumatic stress disorder","volume":"59","author":"Abdallah","year":"2019","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/biom11050641","article-title":"Moderating effects of BDNF genetic variants and smoking on cognition in PTSD veterans","volume":"11","author":"Erjavec","year":"2021","journal-title":"Biomolecules."},{"key":"B128","doi-asserted-by":"publisher","first-page":"006","DOI":"10.4172\/2167-1044.S4-006","article-title":"The role of BDNF-TrkB signaling in the pathogenesis of PTSD","volume":"2013","author":"Green","year":"2013","journal-title":"J Depress Anxiety."},{"key":"B129","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/jcm6120108","article-title":"The impact of the brain-derived neurotrophic factor gene on trauma and spatial processing","volume":"6","author":"Miller","year":"2017","journal-title":"J Clin Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"e0241928","DOI":"10.1371\/journal.pone.0241928","article-title":"Peripheral blood levels of brain-derived neurotrophic factor in patients with post-traumatic stress disorder (PTSD): a systematic review and meta-analysis","volume":"15","author":"Mojtabavi","year":"2020","journal-title":"PLoS ONE."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5498\/wjp.v6.i1.1","article-title":"Post-traumatic stress disorder risk and brain-derived neurotrophic factor Val66Met","volume":"6","author":"Zhang","year":"2016","journal-title":"World J Psychiatry."},{"key":"B132","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front Cell Neurosci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fncel.2020.00082","article-title":"The role of BDNF on neural plasticity in depression","volume":"14","author":"Yang","year":"2020","journal-title":"Front Cell Neurosci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.bbr.2016.05.056","article-title":"Activation of Sigma-1 receptor ameliorates anxiety-like behavior and cognitive impairments in a rat model of post-traumatic stress disorder","volume":"311","author":"Ji","year":"2016","journal-title":"Behav Brain Res."},{"key":"B135","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fcell.2020.00682","article-title":"Long-term effect of post-traumatic stress in adolescence on dendrite development and H3K9me2\/BDNF expression in male rat hippocampus and prefrontal cortex","volume":"8","author":"Zhao","year":"2020","journal-title":"Front Cell Dev Biol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/jcph.1995","article-title":"MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: a systematic review with meta-analysis","volume":"62","author":"Smith","year":"2022","journal-title":"J Clin Pharmacol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41386-019-0482-9","article-title":"MDMA-assisted psychotherapy for posttraumatic stress disorder: a promising novel approach to treatment","volume":"45","author":"Vermetten","year":"2020","journal-title":"Neuropsychopharmacology."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/scan\/nst161","article-title":"MDMA enhances emotional empathy and prosocial behavior","volume":"9","author":"Hysek","year":"2014","journal-title":"Soc Cogn Affect Neurosci."},{"key":"B139","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10879-017-9379-2","article-title":"Current perspective on MDMA-assisted psychotherapy for posttraumatic stress disorder","volume":"48","author":"Thal","year":"2018","journal-title":"J Contemp Psychother."},{"key":"B140","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacol Rev."},{"key":"B141","doi-asserted-by":"publisher","first-page":"748359","DOI":"10.3389\/fnmol.2021.748359","article-title":"Serotonergic psychedelics in neural plasticity","volume":"14","author":"Lukasiewicz","year":"2021","journal-title":"Front Mol Neurosci."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e15070","DOI":"10.7759\/cureus.15070","article-title":"The efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for post-traumatic stress disorder in humans: a systematic review and meta-analysis","volume":"13","author":"Tedesco","year":"2021","journal-title":"Cureus."},{"key":"B143","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00213-013-3304-5","article-title":"MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density","volume":"231","author":"Abad","year":"2013","journal-title":"Psychopharmacology."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e634","DOI":"10.1038\/tp.2015.138","article-title":"3, 4-Methylenedioxymethamphetamine facilitates fear extinction learning","volume":"5","author":"Young","year":"2015","journal-title":"Transl Psychiatry."},{"key":"B145","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1179069518800508","DOI":"10.1177\/1179069518800508","article-title":"Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics","volume":"12","author":"Olson","year":"2018","journal-title":"J. Exp. Neurosci."},{"key":"B147","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.physbeh.2018.12.007","article-title":"3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats","volume":"199","author":"Hake","year":"2019","journal-title":"Physiol Behav."},{"key":"B148","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/cpt.565","article-title":"Potential psychiatric uses for MDMA","volume":"101","author":"Yazar-Klosinski","year":"2017","journal-title":"Clin Pharmacol Ther."},{"key":"B149","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neulet.2006.03.055","article-title":"Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) on BDNF mRNA expression in rat frontal cortex and hippocampus","volume":"402","author":"Mart\u00ednez-Turrillas","year":"2006","journal-title":"Neurosci Lett."},{"key":"B150","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1177\/0004867418824018","article-title":"Current status of psychedelic therapy in Australia and New Zealand: Are we falling behind?","volume":"53","author":"Inserra","year":"2019","journal-title":"Aust N J Psychiatry."},{"key":"B151","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/pnp.216","article-title":"Could MDMA be useful in the treatment of post-traumatic stress disorder?","volume":"15","year":"2011","journal-title":"Prog Neurol Psychiatr."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.991753\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T05:22:37Z","timestamp":1665552157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.991753\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":151,"alternative-id":["10.3389\/fpsyt.2022.991753"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.991753","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"article-number":"991753"}}